Pathogenic Substantiation of Application of Erythropoietin Modified Forms and Peptide Analogues as Cytotprotectors

Pharmacy Formulas
doi 10.17816/phf21382
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ECO-Vector LLC